Literature DB >> 2672824

Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin.

M Rampart1, J Van Damme, L Zonnekeyn, A G Herman.   

Abstract

Granulocyte chemotactic protein/Interleukin-8 (GCP/IL-8), purified to homogeneity from endotoxin- or mitogen-stimulated human mononuclear cells, was injected intradermally into rabbits to evaluate the proinflammatory properties of this novel cytokine. In the presence of a vasodilator substance, pmol amounts of GCP/IL-8 induced neutrophil accumulation that was fast in onset, relatively short of duration (half life 60 to 70 minutes), and was associated with a parallel time course of plasma protein extravasation. GCP/IL-8-induced edema formation was found to be neutrophil dependent. These data provide evidence that GCP/IL-8 fulfills two important criteria for consideration as an inflammatory mediator. It is possible that endogenous GCP/IL-8, if produced locally by tissue macrophages, may contribute to the initiation of the inflammatory response to infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672824      PMCID: PMC1880227     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  Novel neutrophil-stimulating peptides.

Authors:  J Westwick; S W Li; R D Camp
Journal:  Immunol Today       Date:  1989-05

2.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

3.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes.

Authors:  J Schmid; C Weissmann
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

5.  Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales.

Authors:  J M Schröder; E Christophers
Journal:  J Invest Dermatol       Date:  1986-07       Impact factor: 8.551

6.  The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.

Authors:  H Z Movat; C Rettl; C E Burrowes; M G Johnston
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

7.  Vascular responses during acute neutrophilic inflammation. Their relationship to in vivo neutrophil emigration.

Authors:  A C Issekutz
Journal:  Lab Invest       Date:  1981-11       Impact factor: 5.662

8.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

9.  A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity.

Authors:  J Van Damme; J Van Beeumen; G Opdenakker; A Billiau
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a.

Authors:  T J Williams; P J Jose
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  28 in total

1.  The role of CD18 in IL-8 induced dermal and synovial inflammation.

Authors:  M J Forrest; G J Eiermann; R Meurer; L A Walakovits; D E MacIntyre
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

2.  Hydrocortisone-induced anti-inflammatory effects in immature human enterocytes depend on the timing of exposure.

Authors:  Samuli Rautava; W Allan Walker; Lei Lu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-07       Impact factor: 4.052

3.  Induction of neutrophil infiltration by rat chemotactic cytokine (CINC) and its inhibition by dexamethasone in rats.

Authors:  N Hirasawa; M Watanabe; S Mue; K Watanabe; S Tsurufuji; K Ohuchi
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

4.  Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway.

Authors:  Sunil K Manna; Govindarajan T Ramesh
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

5.  Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms.

Authors:  H G Folkesson; M A Matthay; C A Hébert; V C Broaddus
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

6.  Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.

Authors:  L Mazzucchelli; C Hauser; K Zgraggen; H Wagner; M Hess; J A Laissue; C Mueller
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

7.  Inhibition of chemotaxis of neutrophil leukocytes to interleukin-8 by endotoxins of various bacteria.

Authors:  L P Bignold; S D Rogers; T M Siaw; J Bahnisch
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  Heparin potentiates in vivo neutrophil migration induced by IL-8.

Authors:  M Dias-Baruffi; G Pereira-da-Silva; M C Jamur; M C Roque-Barreira
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

9.  In vivo role of phagocytic synovial lining cells in onset of experimental arthritis.

Authors:  P L Van Lent; A E Van den Hoek; L A Van den Bersselaar; M F Spanjaards; N Van Rooijen; C D Dijkstra; L B Van de Putte; W B Van den Berg
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

10.  Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes.

Authors:  P H Nibbering; O Pos; A Stevenhagen; R Van Furth
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.